Serum Ferritin In CKD Patients Serum Ferritin (Ferritin)

July 9, 2023 updated by: Reham Mahmoud Osman, Assiut University

Variability of Serum Ferritin in CKD Patients and How These Variables May Affect the Treatment Decisions With Iron

Variability of serum ferritin in CKD patients and how these variables may affect the treatment decisions with iron supplements

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Serum ferritin has a wide range Variability in CKD patients this makes the use of serum ferritin as an indicator of iron deficiency is limited and mostly CKD is secondary to inflammation so serum ferritin as ferritin is an acute phase reactants so it will be very high in CKD patients ,

Study Type

Observational

Enrollment (Estimated)

55

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Egypt
      • Assiut, Egypt
        • Recruiting
        • Assiut University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

ALL CKD patients who are not dialysis Stage 3 to 5

Description

Inclusion Criteria:

  • ALL CKD patients stage 3 to 5 not on dialysis

Exclusion Criteria:

  • inflammatory chronic diseases IDA Autoimmune disorders Liver diseases Malignancy Infections

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Chronic kidney disease Patients
Chronic kidney Disease Patients stage 3 to stage 5
Drug: Serum ferritin
Serum ferritin in CKD patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
to assess the role of serum ferritin in CKD patients din in CKD patients and how these variability
Time Frame: Recurring
affect treatment decisions with iron
Recurring

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Investigators

  • Study Director: Hawaid Ab Nafady, Professor, Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 8, 2023

Primary Completion (Estimated)

January 11, 2025

Study Completion (Estimated)

January 11, 2025

Study Registration Dates

First Submitted

May 23, 2023

First Submitted That Met QC Criteria

July 9, 2023

First Posted (Actual)

July 17, 2023

Study Record Updates

Last Update Posted (Actual)

July 17, 2023

Last Update Submitted That Met QC Criteria

July 9, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Serum Ferritin in CKD patients

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Diseases

Clinical Trials on Serum ferritin

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe